1. Home
  2. FURY vs IMMX Comparison

FURY vs IMMX Comparison

Compare FURY & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fury Gold Mines Limited

FURY

Fury Gold Mines Limited

HOLD

Current Price

$0.54

Market Cap

111.2M

ML Signal

HOLD

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$9.76

Market Cap

629.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FURY
IMMX
Founded
2008
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Medicinal Chemicals and Botanical Products
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.2M
629.3M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
FURY
IMMX
Price
$0.54
$9.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$1.70
$19.20
AVG Volume (30 Days)
242.4K
1.5M
Earning Date
08-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$1.94
52 Week High
$1.02
$11.61

Technical Indicators

Market Signals
Indicator
FURY
IMMX
Relative Strength Index (RSI) 49.17 59.36
Support Level $0.51 $7.99
Resistance Level $0.63 $9.77
Average True Range (ATR) 0.03 0.74
MACD 0.00 0.20
Stochastic Oscillator 56.88 73.16

Price Performance

Historical Comparison
FURY
IMMX

About FURY Fury Gold Mines Limited

Fury Gold Mines Ltd is a Canadian-focused high-grade gold exploration company. The company's projects are strategically positioned in two prolific mining regions: the Eeyou Istchee James Bay Region of Quebec and the Kitikmeot Region in Nunavut. Fury Gold's project portfolio comprises the Committee Bay gold project in Nunavut, and the Eau Claire gold, Sakami gold, Elmer East gold and lithium, and Eleonore South gold projects in Quebec. Additionally, it also owns interests in the Kipawa rare earths project and has full ownership of the Zeus heavy rare earths project, both located in the Temiscamingue region of Quebec. The company operates in two reportable segments: Quebec and Nunavut.

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Share on Social Networks: